News Focus
News Focus
Followers 797
Posts 86136
Boards Moderated 3
Alias Born 12/25/2009

Re: HokieHead post# 3315

Monday, 10/21/2024 8:36:37 PM

Monday, October 21, 2024 8:36:37 PM

Post# of 4944
July of 2023 ELTP was trading right were we are now .03-04 with that comparison BNCM has a perfect blue print to follow for .70-$1 PPS I like it: "Do some comparisons on Elite Pharma and Delex Pharma.

Elite Pharma:
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and distributes niche generic products. Elite's product lines consist of immediate-release and controlled-release, solid oral dose products, which are marketed under the Elite Laboratories label, as well as pursuant to licenses granted to third-party pharmaceutical marketing and distribution organizations.

OS: 1.1b
PPS: $0.70
Market Cap: $750m
2023 sales: $56m
PS ratio: 14

If Delex can do $40-$50m in 2024 sales and trade at just 10x sales in comparison you have a $500m company.

With the following post merger OS:
1b = $0.50 PPS
750m = $0.75 PPS
500m = $1 PPS
250m = $2 PPS

If the float is only 10m-30m post merger, as most will be restricted, these numbers will be too low.

Monster move coming as this all plays out."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y